TGFB1 and ovarian cancer: Aditya Parikh et al. demonstrated that miR‐181a promoted TGF‐β‐mediated EMT, and its overexpression increased survival, migration, invasion and drug (cisplatin) resistance in A2780 cells,33 histologically unidentified ovarian cancer cell line but putatively endometrioid‐clear cell.34